Žabljak
Pretežno oblačno
-10.6 °C
Pljevlja
Malo oblačno
-5.0 °C
Herceg Novi
Vedro
6.1 °C
Nikšić
Malo oblačno
-2.5 °C
Cetinje
Pretežno vedro
0.5 °C
Bar
Vedro
5.8 °C
Ulcinj
Vedro
4.8 °C
Kolašin
Pretežno oblačno
-4.9 °C

We use cookies and google analytics tool to optimize the delivery of digital advertising to you. If you decline personalization of ads you will still see digital advertisements, but they will not be as relevant to you. We never collect sensitive information, and do not sell any of the data we collect. Under the GDPR regulations browser cookies are now considered sudo-anonymized personal data and since we use cookies to deliver relevant advertisements to you we would like to get your permission to do so.

I don't want my data to be used anymore for analytic purposes.

World

01. 12. 2020. 00:00   >>  16:34 0

AGAINST CORONA

BioNTech and Pfizer are asking Europe to approve their vaccine

The German pharmaceutical company BioNTech and its US partner Pfizer say they have submitted an application for conditional approval of their coronavirus vaccine with the European Medicines Agency.

The two companies said Tuesday that the submission, which occurred Monday, completes the rolling review process they initiated with the agency on October 6.

The move comes a day after rival Moderna said it was asking US and European regulators to allow emergency use of its COVID-19 vaccine.

BioNTech said if the vaccine, currently named BNT162b2, is approved, its use in Europe could begin before the end of 2020.

Komentari 0

ostavi komentar

Ostavi komentar

Pravila komentarisanja sadržaja Portala RTCG
Poštujući načelo demokratičnosti, kao i pravo građana da slobodno i kritički iznose mišljenje o pojavama, procesima, događajima i ličnostima, u cilju razvijanja kulture javnog dijaloga, na Portalu nijesu dozvoljeni komentari koji vrijeđaju dostojanstvo ličnosti ili sadrže prijetnje, govor mržnje, neprovjerene optužbe, kao i rasističke poruke. Nijesu dozvoljeni ni komentari kojima se narušava nacionalna, vjerska i rodna ravnopravnost ili podstiče mržnja prema LGBT populaciji. Neće biti objavljeni ni komentari pisani velikim slovima i obimni "copy/paste" sadrzaji knjiga i publikacija.Zadržavamo pravo kraćenja komentara.

Da biste komentarisali vijesti pod vašim imenom

Ulogujte se

Novo